<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: fda approved</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'fda approved'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22fda+approved%22&t=%22fda+approved%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:17:51 +0100</lastBuildDate>
        <item>
            <title>Research and clinical trials</title>
            <link>http://www.medworm.com/index.php?rid=5028517&amp;cid=t_106154_111_f&amp;fid=39123&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fnursingcomments%2Ftdtc%2F%7E3%2FTIy93UnlV6M%2F</link>
            <description>I was doing some research on clinical trials and it is much more complex than I dreamed!  First of all, any new treatment must go through numerous stages of testing before its benefits and risks can completely be known.  New treatments are discovered in the laboratory and it can take many years of research before they are given to patients.  Why?  Because it is essential to identify that the new treatment is actually better than what is already available.  These research studies are also called clinical trials.  If a treatment has definite potential in the final stages of development, then research is carried out in patients with the particular type of illness that the treatment aims to help.  Furthermore, I always believed that clinical trials were only regarding drugs, and that is...</description>
            <author>Nursing Comments</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5028517</comments>
            <pubDate>Thu, 14 Jul 2011 15:37:10 +0100</pubDate>
            <guid isPermaLink="false">5028517</guid>        </item>
        <item>
            <title>FDA-Approved Drugs Are Not Always Effective: The Benefits Of Alternative Medicine</title>
            <link>http://www.medworm.com/index.php?rid=4968489&amp;cid=t_106154_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Ffda-approved-drugs-are-not-always-effective-the-benefits-of-alternative-medicine%2F2011.06.25</link>
            <description>On Saturday, while thousands of Boston Bruins fans gathered at Government Center to celebrate the team’s recent Stanley Cup victory, a hundred or so true die-hards met a few blocks away at a Massachusetts General Hospital conference to talk about complementary and alternative medicine for psychiatric disorders. While I hated to miss the Bruins parade, I’m glad I attended the MGH conference.
I’ve always been a bit of a skeptic about so-called natural therapies for one simple reason: they don’t have to go through the same rigorous testing in clinical trials that medications do. At the same time, I realize that FDA-approved drugs don’t work for everyone. One in three adults with major depression, for example, can’t completely improve their mood and other symptoms even after trying...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4968489</comments>
            <pubDate>Sat, 25 Jun 2011 21:00:31 +0100</pubDate>
            <guid isPermaLink="false">4968489</guid>        </item>
        <item>
            <title>Flibanserin: Another Pre-FDA Approval Drug Hype</title>
            <link>http://www.medworm.com/index.php?rid=3665971&amp;cid=t_106154_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fflibanserin-another-pre-fda-approval-drug-hype%2F2010.06.15</link>
            <description>This week the FDA will vote on flibanserin, the much-talked-about drug for women with the condition called hypoactive sexual desire disorder or &amp;#8212; because everything in sexual health needs an acronym like ED or PE &amp;#8212; HSDD.
On the eve of the FDA vote, CBS last week ran still another story about flibanserin. This drug has received so much news coverage, you&amp;#8217;d think it cures cancer.
And CBS did little more than promote the hype even more, saying FDA approval &amp;#8220;could translate into a $2 billion market in this country alone&amp;#8221; and then failing to challenge the disease-mongering estimate of &amp;#8220;10 percent to 30 percent of women&amp;#8221; with this condition. It all just goes along with the drug company&amp;#8217;s efforts to build a demand before the drug is even approved. (...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3665971</comments>
            <pubDate>Wed, 16 Jun 2010 02:00:41 +0100</pubDate>
            <guid isPermaLink="false">3665971</guid>        </item>
        <item>
            <title>JAMA Reports PRP Not Effective – A Poorly Designed Study</title>
            <link>http://www.medworm.com/index.php?rid=3176015&amp;cid=t_106154_122_f&amp;fid=35055&amp;url=http%3A%2F%2Fsarasotaneurology.com%2F2010%2F01%2F15%2Fjama-reports-prp-not-effective-a-poorly-designed-study%2F</link>
            <description>In conclusion, PRP is a highly effective medical treatment for ligament, tendon, muscle and other knee/shoulder injuries as well as lower back pain. Even patients with post-operative knee pain or shoulder pain can benefit from PRP therapy.  Outcomes are entirely dependent on the preparation and handling of the blood, equipment used and experience as well as skill of the treating physician. Additional information on PRP can be found at PRP Stops Pain. Excellent clinical study references can be found by clicking here. (Source: Sarasota Neurology)</description>
            <author>Sarasota Neurology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3176015</comments>
            <pubDate>Fri, 15 Jan 2010 14:20:35 +0100</pubDate>
            <guid isPermaLink="false">3176015</guid>        </item>
        <item>
            <title>FDA Wants Your Comments on ECT</title>
            <link>http://www.medworm.com/index.php?rid=3079384&amp;cid=t_106154_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F12%2F11%2Ffda-wants-your-comments-on-ect%2F</link>
            <description>The good folks over at the Committee for Truth in Psychiatry (a national organization for people who&amp;#8217;ve had electroconvulsive therapy - ECT) wanted me to remind you that the U.S. Food and Drug Administration (FDA) is seeking comments on the safety and efficacy of electroconvulsive devices. You may not be aware, but these devices &amp;#8212; which deliver electrical impulses to your brain! &amp;#8212; have never been tested by the FDA for either safety of efficacy.
Let me repeat that &amp;#8211; the FDA has never approved ECT devices for safety or efficacy. 
Doctors today can apply electrical impulses to your brain without having any government agency approve such treatment, despite the fact that ECT in most people results in sometimes-significant memory loss. We wrote about FDA&amp;#8217;s desire to...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3079384</comments>
            <pubDate>Fri, 11 Dec 2009 10:35:05 +0100</pubDate>
            <guid isPermaLink="false">3079384</guid>        </item>
        <item>
            <title>Regenerative Medicine – Platelet Rich Plasma Provides Joint Pain Relief</title>
            <link>http://www.medworm.com/index.php?rid=2927454&amp;cid=t_106154_122_f&amp;fid=35055&amp;url=http%3A%2F%2Fsarasotaneurology.com%2F2009%2F10%2F25%2Fregenerative-medicine-platelet-rich-plasma-provides-joint-pain-relief%2F</link>
            <description>As a neurologist who sees many patients with neck, back and various joint pains, I practice an area of medicine known as neuro-orthopedics. As such, I treat patients for their pain without surgical intervention. Many patients with neck, back and joint pain (knee pain, shoulder pain, elbow pain, etc.) can be successfully treated without invasive surgery and the many risk that go along with this. With surgery there is also a prolonged recovery time and need for extensive rehabilitation. The area of medicine that applies to successfully treating patients without surgery or use of narcotic medications is known as regenerative medicine. In this field, platelet rich plasma is injected into the affected joint, tendon, ligament or soft tissue area that has pain and is failing to heal completely. T...</description>
            <author>Sarasota Neurology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2927454</comments>
            <pubDate>Sun, 25 Oct 2009 21:00:24 +0100</pubDate>
            <guid isPermaLink="false">2927454</guid>        </item>
        <item>
            <title>First &quot;Pharming&quot; Drug Approved</title>
            <link>http://www.medworm.com/index.php?rid=2167479&amp;cid=t_106154_87_f&amp;fid=34825&amp;url=http%3A%2F%2Fwww.wesleyjsmith.com%2Fblog%2F2009%2F02%2Ffirst-pharming-drug-approved.html</link>
            <description>Dolly the sheep was cloned because the administrator Ian Wilmut, and the team that did the deed, hoped to create a herd of genetically altered sheep through cloning and inserting human genes that would result in the sheep producing milk containing properties that could be extracted and turned into medicine--a process dubbed &quot;pharming.&quot; That enterprise failed financially and Wilmut went onto human cloning research before quitting that--good for him--to pursue induced pluripotent stem cell (IPSC) investigations.Where Wilmut and team failed, a different group succeeded. The first medicine derived through pharming has received FDA approval. From the story:U.S. health officials on Friday approved the first drug made using genetically engineered animals despite lingering concerns over health and...</description>
            <author>Secondhand Smoke</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2167479</comments>
            <pubDate>Fri, 06 Feb 2009 22:47:00 +0100</pubDate>
            <guid isPermaLink="false">2167479</guid>        </item>
        <item>
            <title>Alzheimer’s drug may help Down syndrome kids</title>
            <link>http://www.medworm.com/index.php?rid=1895043&amp;cid=t_106154_131_f&amp;fid=34989&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FGeneticsHealth%2F%7E3%2Fq27N3Quhfbc%2F</link>
            <description>Medications that have been slowing the mental decline in Alzheimer&amp;#8217;s patients are showing promise as drugs that can boost the mental skills of children with Down Syndrome. 
Two of those promising drugs are Aricept and Exelon, which were found to increase skill levels of Down syndrome children in small clinical trials. Aricept and Exelon are FDA-approved drugs for treating Alzheimer&amp;#8217;s. Doctors had observed that adults with Down Syndrome were developing Alzheimer&amp;#8217;s disease at an earlier age than the general population. The drugs were given to children, in appropriate doses, to test if they could delay the development of the illness. The results surprised the physicians. 
In a very short period of time, the children&amp;#8217;s communication skills and understanding improved. Dr...</description>
            <author>Genetics and Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1895043</comments>
            <pubDate>Wed, 22 Oct 2008 08:24:32 +0100</pubDate>
            <guid isPermaLink="false">1895043</guid>        </item>
        <item>
            <title>Parkinson’s Disease May Benefit From Early Deep Brain Stimulation</title>
            <link>http://www.medworm.com/index.php?rid=1603089&amp;cid=t_106154_122_f&amp;fid=35055&amp;url=http%3A%2F%2Fsarasotaneurology.com%2F2008%2F07%2F10%2Fparkinson-disease-may-benefit-from-early-brain-stimulation%2F</link>
            <description>Recent studies have suggested that qualifying Parkinson patients benefit from earlier treatment with deep brain stimulation, as reported in Clinical Neurology News. The study indicates that younger Parkinson disease patients are more likely to benefit from early brain stimulator treatment. There is information that may suggest that this therapy may have a protective effect in delaying the progression of Parkinson&amp;#8217;s disease. Deep brain stimulation (DBS) was FDA approved in 2002 for treatment of Parkinson&amp;#8217;s disease. Symptoms that are best controlled include tremor and dyskinesias although brain stimulation can also help reduce freezing and off time. Younger Parkinson patients develop motor complications such as dyskinesias, off time and freezing much earlier than older patients w...</description>
            <author>Sarasota Neurology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1603089</comments>
            <pubDate>Thu, 10 Jul 2008 10:00:33 +0100</pubDate>
            <guid isPermaLink="false">1603089</guid>        </item>
        <item>
            <title>Heart transplants to become obsolete?</title>
            <link>http://www.medworm.com/index.php?rid=1500096&amp;cid=t_106154_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F306988044%2F</link>
            <description>Heart transplants save the lives of more than 2,100 Americans every year. But many more patients are still waiting for a new heart to become available, and hundreds will die without ever getting a second chance at life.
With that being said researchers are asking the question, &amp;#8220;will heart transplants become a thing of the past?&amp;#8221; Will technology become the answer? Yes and perhaps were the answers!
The HeartMate II is an example of this technology. It is the size of a D-cell battery, with a tube that pokes through the skin and connects to a battery pack. It aids in pumping blood through the body as patients hearts fail.
The HeartMate device has since been approved for use by the Food and Drug Administration (FDA) in April of 2008.

	
		Would you prefer technology to a heart trans...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1500096</comments>
            <pubDate>Sat, 07 Jun 2008 21:33:05 +0100</pubDate>
            <guid isPermaLink="false">1500096</guid>        </item>
    </channel>
</rss>

